These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


365 related items for PubMed ID: 2684395

  • 41. Growth factors and proto-oncogenes in early mouse embryogenesis and tumorigenesis.
    Pavelić K, Pecina Slaus N, Spaventi R.
    Int J Dev Biol; 1991 Sep; 35(3):209-14. PubMed ID: 1814404
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. The c-myc protein is constitutively expressed at elevated levels in colorectal carcinoma cell lines.
    Erisman MD, Scott JK, Watt RA, Astrin SM.
    Oncogene; 1988 Apr; 2(4):367-78. PubMed ID: 3283655
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Constitutive or inducible overexpression of the IGF-2 gene in cells of a human colon carcinoma cell line.
    Lamonerie T, Lavialle C, de Galle B, Binoux M, Brison O.
    Exp Cell Res; 1995 Feb; 216(2):342-51. PubMed ID: 7531153
    [Abstract] [Full Text] [Related]

  • 46. Oncostatin M-specific receptor mediates inhibition of breast cancer cell growth and down-regulation of the c-myc proto-oncogene.
    Liu J, Spence MJ, Wallace PM, Forcier K, Hellström I, Vestal RE.
    Cell Growth Differ; 1997 Jun; 8(6):667-76. PubMed ID: 9186000
    [Abstract] [Full Text] [Related]

  • 47. Mad1 expression in the absence of differentiation: effect of cAMP on the B-lymphoid cell line Reh.
    Naderi S, Blomhoff HK.
    J Cell Physiol; 1999 Jan; 178(1):76-84. PubMed ID: 9886493
    [Abstract] [Full Text] [Related]

  • 48. Isolation and characterization of a differentiation-dependent gene in the human colonic cell line HT29-18.
    Oliva MM, Wu TC, Yang VW.
    Arch Biochem Biophys; 1993 Apr; 302(1):183-92. PubMed ID: 8470895
    [Abstract] [Full Text] [Related]

  • 49. Effects of recombinant human transforming growth factor-beta 1 or/and interleukin-6 on growth inhibition and proto-oncogene c-myc expression in human leukemia cells.
    Feng R, Shen S, Hui H, Jin M.
    Chin Med J (Engl); 1997 Nov; 110(11):847-50. PubMed ID: 9772416
    [Abstract] [Full Text] [Related]

  • 50. Exogenous c-myc gene overexpression interferes with early events in F9 cell differentiation.
    Onclercq R, Babinet C, Cremisi C.
    Oncogene Res; 1989 Nov; 4(4):293-302. PubMed ID: 2671866
    [Abstract] [Full Text] [Related]

  • 51. Effects of growth stimulatory factors on mitogenicity and c-myc expression in poorly differentiated and well differentiated human colon carcinoma cells.
    Mulder KM, Brattain MG.
    Mol Endocrinol; 1989 Aug; 3(8):1215-22. PubMed ID: 2674694
    [Abstract] [Full Text] [Related]

  • 52. Transforming growth factor-beta negatively modulates proliferation and c-fos expression of the human endometrial adenocarcinoma cell line HEC-1-A.
    Bergman CA, Talavera F, Christman GM, Baker VV, Roberts JA, Menon KM.
    Gynecol Oncol; 1997 Apr; 65(1):63-8. PubMed ID: 9103392
    [Abstract] [Full Text] [Related]

  • 53. Dissociation of proto-oncogene induction from growth response in normal human fibroblasts.
    Yaar M, Peacocke M, Cohen MS, Gilchrest BA.
    J Cell Physiol; 1990 Oct; 145(1):39-45. PubMed ID: 2120243
    [Abstract] [Full Text] [Related]

  • 54. Transcription of the c-myc oncogene is altered in spontaneously immortalized rodent fibroblasts.
    Tavassoli M, Shall S.
    Oncogene; 1988 Apr; 2(4):337-45. PubMed ID: 3283652
    [Abstract] [Full Text] [Related]

  • 55. Alterations in growth properties of human papilloma virus type 16 immortalised human cervical keratinocyte cell line correlate with amplification and overexpression of c-myc oncogene.
    Crook T, Greenfield I, Howard J, Stanley M.
    Oncogene; 1990 Apr; 5(4):619-22. PubMed ID: 2158040
    [Abstract] [Full Text] [Related]

  • 56. N-(5-indanylsulfonyl)-N'-(4-chlorophenyl)urea, a novel agent equally cytotoxic to nonproliferating human colon adenocarcinoma cells.
    Houghton PJ, Bailey FC, Germain GS, Grindey GB, Witt BC, Houghton JA.
    Cancer Res; 1990 Jan 15; 50(2):318-22. PubMed ID: 2295071
    [Abstract] [Full Text] [Related]

  • 57. Phosphatidylinositol 3-kinase recruitment by p185erbB-2 and erbB-3 is potently induced by neu differentiation factor/heregulin during mitogenesis and is constitutively elevated in growth factor-independent breast carcinoma cells with c-erbB-2 gene amplification.
    Ram TG, Ethier SP.
    Cell Growth Differ; 1996 May 15; 7(5):551-61. PubMed ID: 8732665
    [Abstract] [Full Text] [Related]

  • 58. Dual control of myc expression through a single DNA binding site targeted by ets family proteins and E2F-1.
    Roussel MF, Davis JN, Cleveland JL, Ghysdael J, Hiebert SW.
    Oncogene; 1994 Feb 15; 9(2):405-15. PubMed ID: 8290253
    [Abstract] [Full Text] [Related]

  • 59. Differential dependence of the tumorigenicity of chemically transformed rat liver epithelial cells on autocrine production of transforming growth factor alpha.
    Duddy SK, Earp HS, Russell WE, Smith GJ, Grisham JW.
    Cell Growth Differ; 1995 Mar 15; 6(3):251-61. PubMed ID: 7794793
    [Abstract] [Full Text] [Related]

  • 60. Morphological and molecular characterization of spontaneous myogenic differentiation in a human rhabdomyosarcoma cell line.
    Shapiro DN, Houghton PJ, Hazelton BJ, Germain GS, Murti KG, Rahman A, Houghton JA.
    Cancer Res; 1990 Sep 15; 50(18):6002-9. PubMed ID: 2203524
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 19.